GKOS Stock Summary and Trading Ideas (Glaukos | NYSE:GKOS)

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

What symbol and exchange does Glaukos shares trade?

Glaukos trades on the NYSE stock market under the symbol GKOS.

What is Glaukos stock price doing today?

As of December 17, 2025, GKOS stock price declined to $112.42 with 814,718 million shares trading.

What is Glaukos's Beta?

GKOS has a beta of 1.21, meaning it tends to be more sensitive to market movements. GKOS has a correlation of 0.17 to the broad based SPY ETF.

How much is Glaukos worth?

GKOS has a market cap of $6.45 billion. This is considered a Mid Cap stock.

How much money does Glaukos make?

Last quarter Glaukos reported $134 million in Revenue and -$.16 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.10.

What is the highest and lowest price Glaukos traded in the last 3 year period?

In the last 3 years, GKOS traded as high as $163.71 and as low as $40.45.

What are the top ETFs holding Glaukos?

The top ETF exchange traded funds that GKOS belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.

Is Glaukos (GKOS) a good investment?

GKOS has underperformed the market in the last year with a return of -23.2%, while SPY returned +12.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in GKOS shares. However, GKOS has outperformed the market in the last 3 month and 2 week periods, returning +36.9% and +4.6%, while SPY returned +2.1% and -1.8%, respectively. This indicates GKOS has been having a stronger performance recently.

What are the support and resistance levels for Glaukos (GKOS)?

GKOS support price is $111.05 and resistance is $116.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GKOS shares will trade within this expected range on the day.